A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry Skin
A Bilateral, Controlled Clinical Trial to Evaluate 2 Different Moisturizer Chassis Formulas for the Relief of Dry Skin
1 other identifier
interventional
46
1 country
1
Brief Summary
Dry skin is characterized by a lack of moisture in the outer layer of the skin and can occur as a result of numerous factors including cold weather, low humidity, age, etc. In this study, the moisturizing benefits of two formulas were evaluated for barrier function improvement/impact when used by women with moderately to severely dry skin on their lower legs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 7, 2016
CompletedFirst Submitted
Initial submission to the registry
August 10, 2020
CompletedFirst Posted
Study publicly available on registry
August 12, 2020
CompletedAugust 12, 2020
August 1, 2020
5 months
August 10, 2020
August 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Change from Baseline to Week 6 in Clinical Grading of Skin Dryness
The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.
Baseline to Week 6
Secondary Outcomes (59)
Mean Change from Baseline to Week 2 in Clinical Grading of Skin Dryness
Baseline to Week 2
Mean Change from Baseline to Week 4 in Clinical Grading of Skin Dryness
Baseline to Week 4
Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Skin Dryness
Regression Baseline to Regression Day 1
Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Skin Dryness
Regression Baseline to Regression Day 4
Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Skin Dryness
Regression Baseline to Regression Day 7
- +54 more secondary outcomes
Study Arms (2)
Regression Group
OTHERThe Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then entered a 2-week regression period (no moisturizer usage).
Non-Regression Group
OTHERThe Non-Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then underwent a physical insult (tape stripping) on the lower legs and continued using the moisturizer for 4 additional days.
Interventions
OTC Monograph Drug. Used twice daily on left or right lower leg per randomization schedule.
Cosmetic Moisturizer. Used twice daily on left or right lower leg per randomization schedule.
Physical insult (tape stripping) on the lower leg after 6 weeks of moisturizer use.
Eligibility Criteria
You may qualify if:
- moderately to severely dry skin on both leg legs, as determined by the investigator.
- Fitzpatrick skin types I-IV
- generally in good health
- routinely uses moisturizers on the legs at least 1-3 times per week.
- if of reproductive potential: using a medically acceptable form of birth control for at least 3 months before the study and willing to continue it for at least 1 month after study completion.
- able to read, write, speak, and understand English.
- willing and able to complete all study instructions.
- has completed the informed consent document including a HIPAA disclosure and photograph release.
You may not qualify if:
- known allergies/sensitivities to adhesive tapes or study product ingredients.
- known skin conditions, uncontrolled medical conditions, or any other condition that could interfere with evaluations/data interpretation or increase risk to the subject.
- any active bacterial/fungal/viral skin infections or susceptibility to such infections.
- females who are pregnant, breastfeeding, or planning to become pregnant in near future.
- compromised/broken skin, tattoos, scarring, excessive hair growth, very uneven skin tone, or other conditions that would interfere with evaluations or increase risk to the subject.
- current participation in another study.
- participation in another study in past 4 weeks.
- employees or relatives of the investigator or study site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thomas J. Stephens & Associates, Inc.
Colorado Springs, Colorado, 80915, United States
Study Officials
- STUDY DIRECTOR
Neena Tierney
Johnson & Johnson Consumer Inc. (J&JCI)
- PRINCIPAL INVESTIGATOR
Kun "Mark" Qian, M.D.
Thomas J. Stephens & Associates, Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The test moisturizers were assigned a product code; each moisturizer was assigned to a subject's right or left lower leg per a randomization schedule. Subjects were blinded to the product identities, and evaluators were blinded to which product was used on each leg. Procedural group was unblinded and based on scheduling at Visit 1.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2020
First Posted
August 12, 2020
Study Start
October 23, 2015
Primary Completion
March 25, 2016
Study Completion
April 7, 2016
Last Updated
August 12, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will share
Johnson \& Johnson Consumer Inc. has an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.